Search

Author/Creator Lawrence, Donald P.

1. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607). Issue 14 (23rd March 2017)

Authors:
Kalinsky, Kevin; Lee, Sandra; Rubin, Krista M.; Lawrence, Donald P.; Iafrarte, Anthony J.; Borger, Darell R.; Margolin, Kim A.; Leitao, Mario M.; Tarhini, Ahmad A.; Koon, Henry B.; Pecora, Andrew L.; Jaslowski, Anthony J.; Cohen, Gary I.; Kuzel, Timothy M.; Lao, Christopher D.; Kirkwood, John M.
Journal:
Cancer
Issue:
Volume 123:Issue 14(2017)
Page Start:
2688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma. (18th May 2015)

Authors:
Sullivan, Ryan J.; Ibrahim, Nageatte; Lawrence, Donald P.; Aldridge, Julie; Giobbie-Hurder, Anita; Hodi, F. Stephen; Flaherty, Keith T.; Conley, Christine; Mier, James W.; Atkins, Michael B.; McDermott, David F.
Journal:
Oncologist
Issue:
Volume 20:Number 6(2015)
Page Start:
617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma. (18th May 2015)

Authors:
Sullivan, Ryan J.; Ibrahim, Nageatte; Lawrence, Donald P.; Aldridge, Julie; Giobbie‐Hurder, Anita; Hodi, F. Stephen; Flaherty, Keith T.; Conley, Christine; Mier, James W.; Atkins, Michael B.; McDermott, David F.
Journal:
Oncologist
Issue:
Volume 20:Number 6(2015)
Page Start:
617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma. (4th May 2018)

Authors:
Mooradian, Meghan J.; Reuben, Alexandre; Prieto, Peter A.; Hazar-Rethinam, Mehlika; Frederick, Dennie T.; Nadres, Brandon; Piris, Adriano; Juneja, Vikram; Cooper, Zachary A.; Sharpe, Arlene H.; Corcoran, Ryan B.; Flaherty, Keith T.; Lawrence, Donald P.; Wargo, Jennifer A.; Sullivan, Ryan J.
Journal:
Oncoimmunology
Issue:
Volume 7:Number 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (1st September 2022)

Authors:
Bai, Xue; Shoushtari, Alexander N.; Betof Warner, Allison; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Quach, Henry T.; Cann, Christopher G.; Zhang, Michael Z.; Pallan, Lalit; Harvey, Catriona; Kim, Michelle S.; Kasumova, Gyulnara; Sharova, Tatyana; Cohen, Justine V.; Law...
Journal:
British journal of dermatology
Issue:
Volume 187:Number 3(2022)
Page Start:
401
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study. (20th May 2022)

Authors:
Bai, Xue; Shoushtari, Alexander N.; Betof Warner, Allison; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Quach, Henry T.; Cann, Christopher G.; Zhang, Michael Z.; Pallan, Lalit; Harvey, Catriona; Kim, Michelle S.; Kasumova, Gyulnara; Sharova, Tatyana; Cohen, Justine V.; Law...
Journal:
British journal of dermatology
Issue:
Volume 187:Number 3(2022)
Page Start:
401
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical activity of ipilimumab for metastatic uveal melanoma. Issue 20 (2nd August 2013)

Authors:
Luke, Jason J.; Callahan, Margaret K.; Postow, Michael A.; Romano, Emanuela; Ramaiya, Nikhil; Bluth, Mark; Giobbie‐Hurder, Anita; Lawrence, Donald P.; Ibrahim, Nageatte; Ott, Patrick A.; Flaherty, Keith T.; Sullivan, Ryan J.; Harding, James J.; D'Angelo, Sandra; Dickson, Mark; Schwartz, Gary K.; ...
Journal:
Cancer
Issue:
Volume 119:Issue 20(2013)
Page Start:
3687
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana‐Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan‐Kettering Cancer Center, and University Hospital of Lausanne experience. Issue 20 (2nd August 2013)

Authors:
Luke, Jason J.; Callahan, Margaret K.; Postow, Michael A.; Romano, Emanuela; Ramaiya, Nikhil; Bluth, Mark; Giobbie‐Hurder, Anita; Lawrence, Donald P.; Ibrahim, Nageatte; Ott, Patrick A.; Flaherty, Keith T.; Sullivan, Ryan J.; Harding, James J.; D'Angelo, Sandra; Dickson, Mark; Schwartz, Gary K.; ...
Journal:
Cancer
Issue:
Volume 119:Issue 20(2013)
Page Start:
3687
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting. (8th November 2020)

Authors:
Durbin, Sienna M.; Zubiri, Leyre; Niemierko, Andrzej; Bardia, Aditya; Sullivan, Ryan J.; McEwen, Corey; Mulvey, Therese M.; Allen, Ian M.; Lawrence, Donald P.; Cohen, Justine V.; Hochberg, Ephraim P.; Ryan, David P.; Petrillo, Laura A.; Reynolds, Kerry L.
Journal:
Oncologist
Issue:
Volume 26:Number 1(2021)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗